Kabra Drugs Ltd.
BSE: 524322 | Sector: Health care |
NSE: N.A. | ISIN Code: INE323K01017 |
BSE 00:00 | 07 Feb | 5.32 |
0 (0.00%) |
OPEN
5.00 |
HIGH
5.32 |
LOW
5.00 |
NSE 05:30 | 01 Jan | Kabra Drugs Ltd |
OPEN | 5.00 |
PREVIOUS CLOSE | 5.32 |
VOLUME | 559 |
52-Week high | 5.70 |
52-Week low | 2.95 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Kabra Drugs Ltd. (KABRADRUGS) - Financial Ratios
Ratios | 2022 | 2021 | 2020 |
Debt-Equity Ratio | 0.00 | 0.00 | 0.00 |
Current Ratio | 0.76 | 0.89 | 0.94 |
Asset turnover ratio | 0.00 | 0.00 | 0.00 |
Inventory turnover ratio | 0.00 | 0.00 | 0.00 |
Debtors turnover ratio | 0.00 | 0.00 | 0.00 |
Interest Coverage ratio | 0.00 | 0.00 | 0.00 |
Operating Margin (%) | 0.00 | 0.00 | 0.00 |
Net Profit Margin (%) | 0.00 | 0.00 | 0.00 |
Return on Capital Employed (%) | 0.00 | 0.00 | 0.00 |
Return on Net Worth (%) | 0.00 | 0.00 | 0.00 |
Quick Links for Kabra Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices